Clinical Data Completes Sale of Genetic, PGx Test Business to Transgenomic | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Clinical Data has completed the sale of its genetic and pharmacogenomic testing and biomarker development business to Transgenomic for $15.5 million, the firms said after the close of the market Wednesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.